Louis Monti, M.D., Ph.D.
Vice President, Translational Medicine
Dr. Monti joined Vistagen as Vice President, Translational Medicine in December 2019. Prior to joining Vistagen, Dr. Monti served in multiple leadership roles at Pherin Pharmaceuticals since its founding in 1991, including President and CEO from July 2018 through November 2020, Executive Vice President from 2002 to July 2018, and Vice President of Research from its founding in 1991 to 2002. Prior to joining Pherin, Dr. Monti held various academic positions at the University of Utah and the University of the Republic, Uruguay. He earned an M.D. from the University of the Republic, Uruguay School of Medicine, and a Ph.D. in Physiology and Pharmacology from the University of Utah. Dr. Monti holds memberships in the New York Academy of Sciences, the American Society of Clinical Psychopharmacology, and the International Brain Organization.